Patent details

Basic Information

Publication number:

EP2968575

PCT Application Number:

US2014030519

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147173777

PCT Publication Number:

WO2014145710

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PARENTERAL DICLOFENAC COMPOSITION

French Title of Invention:

FORMULATION PARENTERALE DE DICLOFENAC

German Title of Invention:

PARENTERALE DICLOFENAC-ZUBEREITUNG

SPC Number:

Dates

Filing date:

17/03/2014

Grant date:

26/06/2019

EP Publication Date:

20/01/2016

PCT Publication Date:

18/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/06/2019

EP B1 Publication Date:

26/06/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/03/2020

Expiration date:

17/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/06/2019

 

 

Name:

Latitude Pharmaceuticals Inc.

Address:

9675 Businesspark Avenue, San Diego, CA 92131, United States (US)

Inventor

1

Name:

OKUMU, Franklin

Address:

United States (US)

2

Name:

CHEN, Andrew X.

Address:

United States (US)

3

Name:

CHEN, Hailiang

Address:

United States (US)

Priority

Priority Number:

201361793356 P

Priority Date:

15/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/107; A61K 31/196; A61K 47/24;

Publication

European Patent Bulletin

Issue number:

201926

Publication date:

26/06/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages